Madrigal Announces Groundbreaking Ketamine Research for PTSD Treatment and Upcoming In-Human Clinical Trials ...Middle East

PR Newswire - News
Madrigal Announces Groundbreaking Ketamine Research for PTSD Treatment and Upcoming In-Human Clinical Trials
KIBBUTZ REIM, Israel, March 13, 2024 /PRNewswire/ -- In a significant advancement for mental health care, Madrigal Mental Care is excited to announce the successful completion of its pivotal nanotechnology research on the use of Ketamine as a treatment for trauma related disorders such as...

Hence then, the article about madrigal announces groundbreaking ketamine research for ptsd treatment and upcoming in human clinical trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Madrigal Announces Groundbreaking Ketamine Research for PTSD Treatment and Upcoming In-Human Clinical Trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News